Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PANOBINOSTAT Cause Concomitant disease aggravated? 28 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Concomitant disease aggravated have been filed in association with PANOBINOSTAT. This represents 1.5% of all adverse event reports for PANOBINOSTAT.

28
Reports of Concomitant disease aggravated with PANOBINOSTAT
1.5%
of all PANOBINOSTAT reports
15
Deaths
16
Hospitalizations

How Dangerous Is Concomitant disease aggravated From PANOBINOSTAT?

Of the 28 reports, 15 (53.6%) resulted in death, 16 (57.1%) required hospitalization, and 2 (7.1%) were considered life-threatening.

Is Concomitant disease aggravated Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PANOBINOSTAT. However, 28 reports have been filed with the FAERS database.

What Other Side Effects Does PANOBINOSTAT Cause?

Diarrhoea (368) Plasma cell myeloma (279) Platelet count decreased (192) Death (190) Malignant neoplasm progression (166) Fatigue (162) Nausea (154) Thrombocytopenia (141) Off label use (112) Vomiting (109)

What Other Drugs Cause Concomitant disease aggravated?

SACUBITRIL\VALSARTAN (533) SECUKINUMAB (461) FINGOLIMOD (425) MACITENTAN (286) OMALIZUMAB (186) SELEXIPAG (166) METHOTREXATE (150) RUXOLITINIB (142) OCTREOTIDE (125) BOSENTAN (123)

Which PANOBINOSTAT Alternatives Have Lower Concomitant disease aggravated Risk?

PANOBINOSTAT vs PANTOPRAZOLE PANOBINOSTAT vs PANTOPRAZOLE ANHYDROUS PANOBINOSTAT vs PANTOTHENIC ACID PANOBINOSTAT vs PAPAVERINE PANOBINOSTAT vs PARACETAMOL

Related Pages

PANOBINOSTAT Full Profile All Concomitant disease aggravated Reports All Drugs Causing Concomitant disease aggravated PANOBINOSTAT Demographics